To meet the growing demands of advanced energy storage and integrated electrochemical sensing technologies, we have presented a bimetallic Mo 2 TiC 2 T x -MXene@NiMoO 4 -based dual-mode electrochemical platform exhibiting high energy storage and biosensing performance. Electrochemical investigations in a standard three-electrode setup demonstrated the efficient faradaic redox activity and the C s of 1917.74 C g −1 , exhibiting the synergistic charge storage mechanism, combining double-layer capacitance with redox-based energy storage. The present developed Mo 2 TiC 2 Tx@NiMoO 4 //AC asymmetric device exhibited remarkable electrochemical performance, with C s = 321.44 C g −1 , the highest energy density (E d ) of 45 Wh kg −1 , and the power density (P d ) of 2467 W/kg. This device can deliver prolonged cycling stability with 80% retention over 5000 continued cycles. The EIS equivalent circuit presents the series resistance (R s ) = 2.45 Ω and charge transfer resistance (Rct) = 11 Ω. The highly stable properties of the present electrode also lead to an effective non-enzymatic uric acid sensor, showing high sensitivity (S) of 0.00468 μA/μM, LOD of 0.1323 μM (at S/N = 3), and LOQ of 0.441 μM, with a wide linear sub-micromolar detection range (LOR) of 50–1200 μM, and showed an excellently stable and selective UA detection response.
No takes yet. Share an insight, caveat, or question.
Shahbaz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: